Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

AMA Grants MycoDART CPT Code For Its Life-Saving Test


MycoDART, Inc., developer of proprietary DNA tests, announced its second patented assay has been granted a CPT code from the American Medical Association. MycoDART-PCR for Aspergillus joins MycoDART-PCR for Candida as one of very few diagnostic devices without FDA clearance to be recognized by the AMA.

MycoDART's rapid diagnostic tests allow for the early detection of invasive fungal infections in immune-compromised patients, such as those undergoing transplants, as well as those with cancer and AIDS. Both tests have been clinically validated and are available for physicians to order from the company's affiliate, RealTime Laboratories, Inc., a Texas based clinical lab accredited by CLIA and the College of American Pathology. MycoDART has also teamed up with several prestigious university hospitals to conduct dual clinical studies.

University of Augusta, UC Davis, University of Pennsylvania, Henry Ford Health, and the University of Texas at Houston are currently at work on a study to collect samples from patients with suspected exposure to Candida. The study will compare results of MycoDART-PCR with those of blood cultures, the current gold standard. The purpose of the studies is to demonstrate efficacy in the clinical environment. Baylor Health System will lead the second study, which will employ the Aspergillus assay.

Dr. Jose Vazquez is an infectious disease specialist at the University of Augusta and is the principal investigator on Candida study. According to Dr. Vazquez, "A reliable diagnostic to quickly and accurately identify these deadly infections is long overdue. Relying on blood culture, which is a hundred year old technology that is often wrong, puts the patients at further risk."

MycoDART-PCR uses a unique process to detect very small amounts of DNA in human samples. Unlike blood cultures, which can take days to get results and are only 50% accurate, MycoDART's accuracy is as high as 95%, and results are available within hours of receiving the specimen. Early and rapid diagnosis of invasive fungal infections is key to saving lives and driving down the cost of treatment.

Immune-compromised patients face mortality within hours of being infected if not treated appropriately. Without an accurate diagnosis, doctors must treat with costly and toxic broad-spectrum antifungals. This treatment leads to lengthier hospital stays and more complications. Targeting the right organism with the most effective drug provides the best possible outcome for the patient, the hospital and the third-party payer.


Related Articles:

Recent Articles

Delivering Care

Hospitals adopt a new normal to ensure safe, positive birthing experiences for patients.

Read More

Stu Clark of Premise Health Featured in Nashville Health Care Council's HEALTH CARE BRASS TACKS Series

Read More

Nashville Health Care Council Hosts Listening Session with Brad Smith, Deputy Administrator of CMS and Director of CMMI

Read More

Senate Health Committee Chairman Alexander Says Congress Should Prepare This Year for the Next Pandemic

Releases white paper with five recommendations, requests feedback by June 26

Read More

Self-Care on the Front Lines of Coronavirus

Physicians, nurses, respiratory therapists and the full complement of support staff at hospitals and clinics are battling coronavirus on the front lines. When caring for others, it's all too easy to forget to take care of yourself.

Read More

The Onsite Foundation Announces New Virtual Support Group for Frontline Healthcare Workers and Medical Staff as part of 'Support in Service' Program

The Onsite Foundation, a 501(c)(3) non-profit public charity, today announced a new support group offering under the Foundation's 'Support in Service' program for frontline healthcare workers and medical staff across the country affected by the COVID-19 pandemic.

Read More

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

Behavioral Health in a Time of Social Isolation

Last month, the Nashville Health Care Council brought together experts for a virtual panel discussion on behavioral health in the midst of social distancing orders.

Read More

COVID-19 & Mental Health

As the virus takes its toll, providers are finding new ways to reach patients and preparing for the mental health fallout ahead.

Read More

Sharing Best Practices in Behavioral Health

Nashville-based online video service provides evidence-based training to public and providers.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: